Co-Authors
This is a "connection" page, showing publications co-authored by Robert Fowler and Francois Lamontagne.
Connection Strength
0.928
-
Anti-Ebola therapy for patients with Ebola virus disease: a systematic review. BMC Infect Dis. 2019 May 02; 19(1):376.
Score: 0.205
-
Evidence-based guidelines for supportive care of patients with Ebola virus disease. Lancet. 2018 02 17; 391(10121):700-708.
Score: 0.184
-
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26; 385(9):790-802.
Score: 0.060
-
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 26; 385(9):777-789.
Score: 0.060
-
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Med. 2021 Aug; 47(8):867-886.
Score: 0.060
-
CMAJ. 2020 10 26; 192(43):E1323-E1333.
Score: 0.057
-
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial. JAMA. 2020 10 06; 324(13):1317-1329.
Score: 0.057
-
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline. CMAJ. 2020 05 19; 192(20):E536-E545.
Score: 0.055
-
Misinformation During the Coronavirus Disease 2019 Outbreak: How Knowledge Emerges From Noise. Crit Care Explor. 2020 Apr; 2(4):e0098.
Score: 0.055
-
7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: a pilot randomized clinical trial. Trials. 2018 Feb 17; 19(1):111.
Score: 0.047
-
An environmental scan of quality indicators in critical care. CMAJ Open. 2017 Jun 21; 5(2):E488-E495.
Score: 0.045
-
Pathogens and antimicrobial susceptibility profiles in critically ill patients with bloodstream infections: a descriptive study. CMAJ Open. 2016 Oct-Dec; 4(4):E569-E577.
Score: 0.043